Is Oculopharyngeal muscular dystrophy hereditary?

Oculopharyngeal muscular dystrophy is an inherited genetic condition caused by an expansion mutation in the PABPN1 gene. Because it follows an autosomal dominant inheritance pattern, an individual with Oculopharyngeal muscular dystrophy has a 50% chance of passing the genetic mutation to each of their children.

Is Oculopharyngeal muscular dystrophy hereditary?

Yes, Oculopharyngeal muscular dystrophy is both genetic and hereditary. "Genetic" means the condition is caused by a change in DNA, while "hereditary" means this change is passed down from parents to children through germline cells. In almost all cases, Oculopharyngeal muscular dystrophy is inherited from an affected parent. It is caused by a GCG repeat expansion in the PABPN1 gene on chromosome 14, which leads to the accumulation of abnormal proteins in muscle cells, primarily affecting the eyelids and throat.

How is Oculopharyngeal muscular dystrophy inherited?

Oculopharyngeal muscular dystrophy typically follows an autosomal dominant inheritance pattern. This means that a person only needs to inherit one copy of the mutated PABPN1 gene from one affected parent to develop the disease. While the condition can sometimes appear in individuals with no known family history, this is rarely due to a de novo (spontaneous) mutation; it is more often due to incomplete penetrance, late onset of symptoms in a parent, or misdiagnosis within the family. Because Oculopharyngeal muscular dystrophy symptoms often do not manifest until the patient is in their 40s or 50s, a parent may be unaware they carry the gene until after they have had children.

What are the risks to family members and children?

If one parent carries the PABPN1 mutation associated with Oculopharyngeal muscular dystrophy, the risks for family planning and inheritance are as follows:

• Inheritance Probability: There is a 50% chance for each child to inherit the expansion mutation.


• Variable Expressivity: Even if a child inherits the gene, the severity and age of onset can vary significantly between family members.


• Genetic Testing: Molecular genetic testing is available to confirm the presence of the PABPN1 expansion. It is recommended for symptomatic individuals and for asymptomatic at-risk relatives who wish to know their genetic status.


• Reproductive Options: Families may explore prenatal diagnosis or preimplantation genetic testing (PGT) to screen embryos for the mutation, though these options should be discussed thoroughly with a genetic counselor.

What is the role of genetic counseling?

Genetic counseling is a vital step for any family affected by Oculopharyngeal muscular dystrophy. A counselor helps families understand the autosomal dominant nature of the condition, assists in interpreting test results, and provides emotional support regarding the implications of a diagnosis. With 164 members of the DiseaseMaps.org community sharing their experiences with Oculopharyngeal muscular dystrophy, many families find that connecting with others who have navigated these complex genetic decisions provides invaluable perspective and comfort.

Next steps

• Consult with a clinical geneticist or a neurologist specializing in neuromuscular disorders to discuss genetic testing.


• Speak with a certified genetic counselor to map out your family history and understand the inheritance risks for your children.


• Join the DiseaseMaps.org community to connect with other patients and caregivers who are managing the daily realities of Oculopharyngeal muscular dystrophy.


• Stay informed about clinical research and patient advocacy through established foundations like the Muscular Dystrophy Association (MDA).

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Oculopharyngeal muscular dystrophy.


• Orphanet: Oculopharyngeal muscular dystrophy (ORPHA:264).


• OMIM (Online Mendelian Inheritance in Man): PABPN1 Gene; #164300.


• Muscular Dystrophy Association (MDA): Oculopharyngeal Muscular Dystrophy (OPMD) Overview.